About Us | News & Press Releases
Press Archives
News
Record Journal - April 12, 2007
Report in AMA journal Excited Protein Sciences
The Denver Press - April 11, 2007
Flu Vaccine's Worm Turns in Caterpillar Experiment
USA Today - April 11, 2007
Flu Vaccine Emerges From Caterpillar Cells
Science Daily - April 11, 2007
Pandemic Fears? Try Growing Flu Vaccine Fast in Insect Cells
Los Angeles Times - April 10, 2007
HealthDay Reporter - April 10, 2007
Flu Vaccine Grown in Insect Cells Called a Promising Alternative
The Record Journal - December 20, 2005
Protein Sciences chosen
The Record Journal - November 5, 2005
Protein Sciences Enlisting Help Of U.S. Congress Officials In Seeking Funding
The Record Journal - October 9, 2004
Protein Sciences is in Phase III of new kind of shot
The Hartford Courant - October 15, 2004
Suddenly Cinderella
Denver Post - October 20, 2004
Flu-vaccine process gets a shot in the arm
BioWorld Today - November 1, 2004
Protein Sciences' FluBlØk Moves to Phase II/III Work
Bioprocess International - June 2004
Commercial Production in Insect Cells- One Company's Perspective
Business Week - January 14, 2004
Biotech's Babies: Doing Well By Doing Good
The Hartford Courant - December 26, 2003
For Biotech Firms, A Booster Flu Points To Need For New Vaccines
Press Releases
August 29, 2006
Protein Sciences Announces Licensing of FluBlok to UNM Pharma for the Japan Market
January 9, 2006
Protein Sciences announces closing of $6 million financing and partnership in diabetes vaccine.
June 14, 2005
Protein Sciences announces excellent efficacy results for FluBlok, it's recombinant influenza vaccine.
October 28, 2004
Protein Sciences Announces FDA Clearance to Conduct Proof of Principle/ Field Trial of FluBlØk™, its Cell-Culture Influenza Vaccine. Enrollment of Subjects to Begin This Week at Three Sites
December 10, 2001
Protein Sciences Corporation (PSC) announced today that it has signed a contract with the National Institute of Allergy and Infections Diseases (NIAID) that provides for up to $76 million in funding through mid-2006 for development and production of antigens for new vaccines for HIV/AIDS.
November 27, 2001
Protein Sciences Corporation (PSC) announced today that it has reacquired all rights to two patented, late stage influenza vaccines.
November 12, 2001
Protein Sciences Corporation (PSC) announced today the closing of a financing of more than $2 million in new equity and restructuring of its balance sheet to eliminate all $27 million in debt, security interests and preferences. Investors include existing and new investors.
October 16, 2000
Northwest Biotherapeutics, Inc. announced today that it has selected Protein Sciences Corporation, Meriden, Connecticut to develop a high yield expression vector for production of a proprietary kidney cancer-specific protein as a component of a new treatment for renal cell carcinoma. The terms of the agreement were not disclosed.
November 30, 2000
Protein Sciences Corporation (PSC) and HTS Biosystems, Inc. (HTS), announced today that they have entered into a strategic collaboration to facilitate the discovery of novel protein molecules for the drug and diagnostics markets through innovative solutions for proteomics.
June 6, 2000
Protein Sciences Corporation (PSC) and Nihon Nosan Kogyo KK (NNK) are pleased to announce today that they have entered into a distribution agreement to market PSC's research products in Japan.
